Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
11%(1 trials)
Terminated
2(18%)

Phase Distribution

Ph not_applicable
10
91%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(2)

Detailed Status

Completed9
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
81.8%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

terminated218%
completed982%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11